Preparation and Evaluation of Meloxicam-loaded Poly(D,L-lactic acid) Microspheres |
Im, Jong-Seob
(College of Pharmacy, Yeungnam University)
Oh, Dong-Hoon (College of Pharmacy, Yeungnam University) Li, Dong-Xun (College of Pharmacy, Yeungnam University) Sung, Jung-Hoon (College of Pharmacy, Yeungnam University) Yoo, Bong-Kyu (College of Pharmacy, Yeungnam University) Kim, Jung-Ae (College of Pharmacy, Yeungnam University) Woo, Jong-Soo (College of Pharmacy, Yeungnam University) Lee, Yong-Bok (College of Pharmacy, Chonnam National University) Kim, Se-Mi (College of Pharmacy, Chonnam National University) Choi, Han-Gon (College of Pharmacy, Yeungnam University) Yong, Chul-Soon (College of Pharmacy, Yeungnam University) |
1 | T. Kawaguchi, A. Tsugane, K. Higashide, H. Endoh, H. Kanno, T. Seki, K. Juni, S. Fukushima and M. Nakino, Control of drug release with a combination of prodrug and polymer matrix, J. Pharm. Sci., 81, 508-512 (1992) DOI |
2 | N. Wakiyama, K. Juni and M. Nakano, Preparation and evaluation in vitro of polylactic acid microspheres containing local anesthetics, Chem. Pharm. Bull., 29, 3363-3368 (1981) DOI ScienceOn |
3 | J.R. Robinson(Ed.), Sustained and Controlled Release Drug Delivery Systems, Marcel Dekker, New York, U.S.A., 1978 |
4 | Y.W. Chien(Ed.), Novel Drug Delivery Systems, Marcel Dekker, New York, U.S.A., 1992 |
5 | A. Schindler, R. Jeffcoat, G.L. Kimmel, C.G. Pitt, M.E. Wall and R. Zweidinger (Eds.), Contemporary Topics in Polymer Science, Plenum Press, New York, U.S.A., pp. 251-286 (1977) |
6 | D.L. Wise, T.D. Fellmann, J.E. Sanderson and R.L. Wentworth( Eds.), Lactic-Glycolic Acid Polymers in Drug Carriers in Biology and Medicine, Academic Press, Orlando, Fla., pp. 237-270 (1979) |
7 | M. Chasin and R. Langer (Eds.), Biodegradable Polymers as Drug Delivery Systems, Marcel Dekker, New York, U.S.A., 1990 |
8 | S.M. Li, H. Garreau and M. Vert, Structure-property relationships in the case of the degradation of massive aliphatic poly-(-hydroxy acids) in aqueous media, part 1:poly(DL-lactic acid), J. Materi. Sci.,; Materials in Medicine, 1, 123-130 (1990) DOI |
9 | K. Makino, M. Arakawa and T. Kondo, Preparation and in vitro degradation properties of polylactide microcapsules, Chem. Pharm. Bull., 33, 1195-1201 (1985) DOI ScienceOn |
10 | I.J. Oh, J.Y. Oh and K.C. Lee, Assessment of biodegradability of polymeric microspheres in vivo: poly(DL-lactic acid), poly(L-lactic acid) and poly(DL-lactide-co-glycolide) microspheres, Arch. Pharm. Res., 16, 312-317 (1993) DOI |
11 | L.R. Beck, D.R. Cowsar, D.H. Lewis, R.J. Cosgrove, C.T. Riddle, S.L. Lowry, and T. Epperly, A new long-acting injectable microcapsule system for the administration of progesterone, Fertility and Sterility, 31, 545-551 (1979) DOI |
12 | K. Juni, J. Ogata, M. Nakano, T. Ichihara, K. Mori and M. Akagi, Preparation and evaluation in vitro of polylactic acid micropsheres containing doxorubicin, Chem. Pharm. Bull., 33, 313-318 (1985) DOI ScienceOn |
13 | L.R. Beck, C.E. Flowers, V.Z. Pope, W.H. Wilborn and T.R. Tice, Clinical evaluation of improved injectable microcapule contraceptive system, Am. J. Obstet. Gynecol., 147, 815-821 (1983) DOI |
14 | K. Suzuki and J.C. Price, Microencapsulation and dissolution properties of a neuroleptic in a biodegradable polymer, poly(d,l-lactide), J. Pharm. Sci., 74, 21-24 (1985) DOI |
15 | N. Wakiyama, K. Juni and M. Nakano, Preparation and evaluation in vitro of polylactic acid microspheres containing dibucaine, Chem. Pharm. Bull., 30, 3719-3727 (1982) DOI ScienceOn |
16 | A.K. Kwong, S. Chou, A.M. Sun, M.V. Sefton and M.F.A. Goosen, In vitro and iv vivo release of insulin from polyl(actic acid) microbeads and pellets, J. Control. Rel., 4, 47-62 (1986) DOI ScienceOn |
17 | G. Spenlehauer, M. Veillard and J.P. Benoit, Formation and characterization of cisplatin loaded poly(d,l-lactide) microspheres for chemoembolization, J. Pharm. Sci., 75, 750-755 (1986) DOI |
18 | Y.W. Chien(Ed.), Novel Drug Delivery Systems, Marcel Dekker, New York, U.S.A., pp. 465-545 (1982) |
19 | B. Xin, Y, Yokoyama, T. Shigeto, H. Mizunuma, Anti-tumor effect of non-steroidal anti-inflammatory drugs on human ovarian cancers. Pathol. Oncol. Res., 13, 365-369(2007) DOI |
20 | G. Dannhardt and W. Kiefer, Cyclooxygenase inhibitors - current status and future prospects, Eur. J. Med. Chem., 36, 109-126 (2001) DOI ScienceOn |
21 | F. Castelli, B. Conti, D.E. Maccarrone, U. Conte and G. Puglisi, Comparative study of 'in vitro' release of antiinflammatory drugs from polylactide-co-glycolide microspheres, 176, Int. J. Pharm., 85-98 (1998) DOI ScienceOn |
22 | N. Buchi Naidu, K.P.R. Chowdary, K.V.R. Murthy, V. Satyanarayana, A.R. Hayman and G. Becket, Physicochemical characterization and dissolution properties of meloxicamcyclodextrin binary systems, J. Pharm. Biomed. Anal., 35, 75-86 (2004) DOI ScienceOn |
23 | B. Dasandi, Shivaprakash, H. Saroj and K.M. Bhat, LC determination and pharmacokinetics of meloxicam., J. Pharm. Biomed. Anal., 28, 999-1004 (2002) DOI ScienceOn |
24 | R.N. Rao, S. Meena and A.R. Rao, An overview of the recent developments in analytical methodologies for determination of COX-2 inhibitors in bulk drugs, pharmaceuticals and biological matrices, J. Pharm. Biomed. Anal., 39, 349-363 (2005) DOI ScienceOn |
25 | P. Luger, K. Daneck, W. Engel, G. Trummlitz and K. Wagner, Structure and physicochemical properties of meloxicam, a new NSAID, Euro. J. Pharm. Sci., 4, 175-187 (1996) DOI ScienceOn |
26 | J. Heller, Biodegradable polymers in controlled drug delivery, CRC Crit. Rev. Ther. Drug. Carrier Systems, 1, 39-90 (1984) |
27 | F.G. Hutchinson and B.J.A. Furr, Biodegradable polymer systems for the sustained release of polypeptides, J. Control. Rel., 13, 279-294 (1990) DOI ScienceOn |
28 | P. Johnson and J.G. Lloyed-Jones(Eds.), Drug Delivery Systems: Fundamentals and Techniques, Ellis Horwood, England Chichester, 1987 |
29 | B. Conti, F. Pavanetto and I. Genta, Use of polylactic acid for the preperation of microparticulate drug delivery system, J. Microencapsulation, 9, 153-166 (1992) DOI |
30 | R.J. Linhardt, Biodegradable polymers for controlled release of drugs: In Controlled Release of Drugs: Polymers and Aggregate Systems, M. Rosoff(Ed.), VCH Publishers, New York, U.S.A., pp. 53-96, (1988) |
31 | C.G. Pitt, M.M. Gratzl, A.R. Jeffcoat, R. Zweidinger and A. Schindler, Sustained drug delivery systems, J. Pharm. Sci. 68, 1534-1538 (1979) DOI |
32 | H. Endoh, T. Kawaguchi, T. Seki, T. Hasegawa and K. Juni, Controlled release of 5-Fluoro-2-deoxyuridine by the combination of prodrug and polymer matrix, Chem. Pharm. Bull., 39, 458-464 (1991) DOI ScienceOn |
33 | I. Yamakawa, Y. Tsushima, R. Machida and S. Watanabe, In vitro and in vivo release of poly(DL-lactic acid) microspheres containing neurotensin analogue prepared by novel oil-in water solvent evaporation method, J. Pharm. Sci., 81, 808-811 (1992) DOI |
34 | J.H.P. Woodland and S. Yolles, Long-acting delivery systems for narcotic antagonists, J. Med. Chem., 16, 897-901 (1973) DOI |
35 | Y. Ogawa, H. Okada, M. Yamamoto and Y. Shimamoto, In vivo release profiles of leuprolide acetate from microcapsules prepared with polylactic acids or copoly(lactic/glycolic) acids in vitro degradation of these polymers, Chem. Pharm. Bull., 36, 2576-2581 (1988) DOI ScienceOn |
36 | R. Jalil, J.R. Nixon, J. Microencapsulation, 7, 297-352 (1990) DOI |
37 | I. Yamakawa, Y. Tsushima, R. Machida and S. Watanabe, Preparation of neurotensin analogue-containing poly(DLlactic acid) microsperes formed by oil-in water solvent evaporation, J. Pharm. Sci., 81, 899-903 (1992) DOI |
38 | B.J.A. Furr and F.G. Hutchinson, A biodegradable delivery system for peptides: Preclinical experience with the gonadotrophin- releasing hormone agonist Zoladex , J. Control. Rel., 21, 117-128 (1992) DOI ScienceOn |
39 | V.R. Sinha and A. Trehan, Biodegradable microspheres for parenteral delivery, Crit. Rev. Ther. Drug Carrier Syst., 22, 535-602 (2005) DOI ScienceOn |
40 | G. Engelhardt, D. Homma, K. Schlegel, R. Utzmann, C. Schnitzler, Anti-inflammatory, analgesic, antipyretic and related properties of meloxicam, a new non-steroidal antiinflammatory agent with favourable gastrointestinal tolerance, Inflamm. Res., 44, 423-433 (1995) DOI |
41 | N.H. Zawilla, M.A.-A. Mohammad, N.M. El-Kousy and S.M. El-Moghazy Aly, Determination of meloxicam in bulk and pharmaceutical formulations, J. Pharm. Biomed. Anal., 32, 1135-1144 (2003) DOI ScienceOn |
42 | M. El-Badry, M. Fathy, Enhancement of the dissolution and permeation rates of meloxicam by formation of its freezedried solid dispersions in polyvinylpyrrolidone K-30, Drug Dev. Ind. Pharm., 32, 141-50(2006) DOI ScienceOn |
43 | J. Schmid, U. Busch, G. Heinzel, G. Bozler, S. Kaschke, M. Kummer, Pharmacokinetics and metabolic pattern after intravenous infusion and oral administration to healthy subjects, Drug Metab. Dispos., 23, 1206-13 (1995) |
44 | T. Velpandian, J. Jaiswal, R.K. Bhardwaj and S.K. Gupta, Development and validation of a new high-performance liquid chromatographic estimation method of meloxicam in biological samples, J. Chroma. B, 738, 431-436 (2000) DOI ScienceOn |
45 | M. Gibaldi, S. Feldman, Establishment of sink conditions in dissolution rate determinations, J. Pharm. Sci., 56, 1238-1242(1967) DOI |
46 | C. Sturesson, J. Carlfors, K. Edsman and M. Andersson, Preparation of biodegradable poly(lactic-co-glycolic)acid microspheres and their in vitro release of timolol maleate, Int. J. Pharm., 89, 235-244 (1993) DOI ScienceOn |
47 | Jain R., Shah N.H., Malick A.W., Rhodes C.T., Drug Dev. Ind. Pharm., 24, 703-727(1998) DOI |
48 | Y. Ogawa, H. Okada, T. Heya and Y. Shimamoto, Controlled release of LHRH agonists, leuprolide acetate, from microcapsules: Serum drug level profiles and pharmacological effects in animals, J. Pharm. Pharmacol., 41, 439-444 (1989) DOI |
49 | N. Seedher and S. Bhatia, Mechanism of interaction of the non-steroidal antiinflammatory drugs meloxicam and nimesulide with serum albumin, J. Pharm. Biomed. Anal., 39, 257-262 (2005) DOI ScienceOn |